Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Gennaro Giustino

Cardiovascular Disease Morristown, NJ Medical Doctor

NPI 1174985113 CMS profile 7233607

100 Madison Ave # Gagnonc, Morristown, NJ 07960

Open in the dashboard

General payments

$134,638

578 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$32,167 paid to institutions, not to them · program year 2025

Through program year 2025, Gennaro Giustino of Morristown, NJ is reported in the CMS Open Payments database as having received $134,638 across 578 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $32,167 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 97th percentile of Cardiovascular Disease profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $99,136 240
2024 General $7,679 73
2023 General $20,140 141
2022 General $2,345 79
2021 General $1,194 26
2020 General $425 8
2019 General $3,719 11

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Gennaro Giustino
  • Cardiovascular Disease median
  • Middle half of Cardiovascular Disease
  • National median

In program year 2025, general payments to Gennaro Giustino were reported at $99,136. Among 16,617 Cardiovascular Disease profiles paid that year, the median was $432 and the middle half received between $132 and $1,252.

Show as a table
Year Gennaro Giustino Cardiovascular Disease median Middle half National median
2019 $3,719 $450 $127–$1,392 $163
2020 $425 $242 $77–$751 $114
2021 $1,194 $335 $101–$1,037 $132
2022 $2,345 $395 $121–$1,211 $149
2023 $20,140 $443 $136–$1,283 $160
2024 $7,679 $450 $136–$1,323 $164
2025 $99,136 $432 $132–$1,252 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Edwards Lifesciences Corporation $91,698 173 payments
  2. Medtronic, Inc. $25,890 103 payments
  3. E.R. Squibb & Sons, L.L.C. $3,829 17 payments
  4. Abbott Laboratories $2,304 50 payments
  5. Shockwave Medical, Inc $2,275 40 payments
  6. AstraZeneca Pharmaceuticals LP $1,331 32 payments
  7. Abiomed $1,256 14 payments
  8. AngioDynamics, Inc. $1,191 11 payments
  9. Terumo Medical Corporation $697 21 payments
  10. Cardiovascular Systems Inc. $683 20 payments
  11. Other $3,484 97 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $70,957 14 payments
  2. Travel and Lodging $25,855 73 payments
  3. Food and Beverage $23,325 488 payments
  4. Grant $13,000 1 payment
  5. Honoraria $900 1 payment
  6. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $600 1 payment
Products named General payments · program years 2019–2025
  1. PASCAL $56,079 42 payments
  2. COREVALVE EVOLUT R $23,740 87 payments
  3. EVOQUE $8,382 12 payments
  4. EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) $6,080 8 payments
  5. ELIQUIS $3,760 13 payments
  6. SAPIEN 3 Ultra RESILIA $2,308 56 payments
  7. Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter Lithoplasty $1,320 33 payments
  8. Impella $1,256 14 payments
  9. ALPHAVAC $1,141 10 payments
  10. Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter Cardiology $955 7 payments
  11. Other $9,346 227 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 27 billing codes

Paid by Medicare

$36,877

Medicare's payments for the services billed

Medicare patients

90

Average age 82

Services billed

253

40 women, 50 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Heart failure 75%
Ischemic heart disease 75%
Chronic kidney disease 75%
Atrial fibrillation 66%
Arthritis 59%
Diabetes 48%
COPD 33%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

2 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
CLEVIPREX
  • CHIESI USA, INC. $9
$9 — —
KENGREAL
  • CHIESI USA, INC. $9
$9 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

578 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Cardiovascular Disease in New Jersey

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record